many who are tested in the clinic do not take a chance and pay for the service themselves.
Aside from insurance issues, psychological factors also play a role in people's decision to be tested. Stopfer agrees with Biesecker's categoriesthe "want-to-knowers" and the "avoiders." She notes that some feel they would have more control over their health care if they knew they inherited an alteration; others decide they could not adjust to a positive test result.
Nevertheless, a recent survey of firstdegree relatives of breast cancer patients found that 90% -at least in theory -wanted to know their individual risk. The most common reasons cited were to learn about their children's risk, to know whether to increase cancer screening tests, and to take better care of themselves.
But moving from theory to the actual decision to be tested is not so simple. Writing in the spring/summer 1995 issue of Hereditary Colon Cancer Newsletter about her first experience offering testing to a large hereditary non-polyposis colorectal cancer family, Pam Chapman, a clinical nurse specialist in genetics at the Northern Genetics Service, Newcastle-upon-Tyne, England, commented about the high level of anxiety of family members as they went through the decision-making process.
"I think the source of this anxiety lies mostly in uncertainty," Chapman wrote. "We cannot predict if or when a person will be affected (with HNPCC), or which organs may be affected. We are not sure which screening protocols to follow, and it is difficult to convince surgeons that gene tests are accurate."
Of the 16 family members who received their test results, most apparently adjusted well to the new information, but a few did need minimal psychological support. "It may surprise you to hear that 'good' results have caused great upset," Chapman noted. "This is a common finding in other genetic disorders, and it is not really surprising when you think how complicated family relations are; if we 'survive' the family problem we feel sad for those who don't and guilty for ourselves." Sometimes, she added, "life decisions are based on a high risk of developing cancer, and if we take away the risk, a major adjustment must begin We all have a great deal to learn in dealing with new genetic information." -Nancy J. Nelson
Behavioral

Research Initiatives Given Emphasis
If Americans stopped smoking cigarettes, consumed less fat, and altered their lifestyles in other health-promoting ways, some experts say the number of annual cancer deaths in the United States would drop by 50% or more. Tobacco use, by itself, may be responsible for 30% of cancer mortality, and behaviors such as poor eating habits and failure to get regular breast screening also contribute to the death toll from cancer.
How 
News News
The National Cancer Institute and other organizations are gearing up to answer that question through several new behavioral research initiatives in caacer. NCI is surveying the extent of current behavioral research, drafting a strategic research plan, and pulling together a working group of scientists to develop RFAs (requests for applications) for new research.
Behavioral Roots
"What you're seeing ... is a recognition that so much of cancer mortality is rooted in behavioral causes," said Barbara Rimer, Dr.P.H., of Duke University and chair of the National Cancer Advisory Board. "If we want to make a difference, we have to attend to those behavioral causes."
The importance of behavior to cancer is reflected in the goals of Healthy People 2000, the set of more than 300 national health objectives the U.S. Public Health Service hopes Americans will achieve by the year 2000. Fifteen of the 16 cancer-related goals directly or indirectly involve behavioral changes such as quitting smoking, increasing mammography use, and eating less fat.
"We have a very long way to go" to reach the Healthy People 2000 goals for cancer, Rimer said. "It's going to take the next generation of behavioral research to really make a difference, and that research has to be interwoven with an understanding of cancer prevention, cancer biology, and cancer treatment."
The next generation of behavioral research in cancer will likely flow, at least in part, from the strategic research plan now taking form, based on some 250 recommendations made in July by a group of behavioral scientists convened by NCT and its advisory group, the National Cancer Advisory Board.
The recommendations cover diet, tobacco use, screening adherence, genetics and behavior, and post-diagnosis quality of life.
One universal concern identified by the conference was children, said Tom Glynn, Ph.D., chief of NCI's Prevention and Control Extramural Research Branch.
Behavioral research might concentrate, for instance, on 8-to 12-year-olds to find out what can be done to keep them from becoming adult smokers, he said. Or it might explore ways to work with young people to ensure that, by the time they are 25 or 30 years old, they are eating at least five daily servings of fruit and vegetables (as recommended by NCI). Such early behavioral changes would produce habits that could greatly reduce mortality from lung, colon, and other major cancers.
RFA Development
Parallel to creation of a strategic plan, a working group chaired by Caryn Lerman, Ph.D., of the Georgetown University's Lombardi Cancer Center, Washington, D.C., will be developing RFAs to solicit research proposals from the scientific community. The RFAs, as well as the strategic plan, will probably go to approving bodies in late summer or early fall, Rimer said.
At the National Institutes of Health level, two RFAs are envisioned to explore specific behaviors, such as smoking, that affect diseases studied at more than one unit of the NIH. One of these RFAs would establish centers for behavioral research oriented toward interventions and applications; the other would provide smaller grants focusing on basic behavioral research. At the NCI level, up to three RFAs might be established to respond Dr. Barbara Rimer to the specific recommendations of the strategic plan.
An estimated 90% of behavioral research at NCI now occurs within the Division of Cancer Prevention and Control. But the next generation of behavioral research will probably include more research into basic mechanisms (What is the relationship between exercise and breast cancer?), more research tied to cancer biology (What steps should be taken by someone who inherits a cancer susceptibility gene?), and more research aimed at cancer treatments (How do you get patients to accept new therapies?). That, Rimer said, means behavioral research could be integrated in some way or another into every NCI division.
Interest in bringing more behavioral science into cancer research has picked up noticeably beyond NCI, too. In July, following a congressional mandate, NIH established the Office of Behavioral and Social Sciences Research, which will coordinate the NIH-level RFAs in NCI's behavioral research initiative.
Office Will Broker
Although the NIH office has no ability to fund grants, it will broker the RFAs among the various institutes concerned with common behaviors, such as diet alteration and smoking cessation.
"Some of the behavioral research in particular that's of interest to the Can-News News cer Institute may also be of interest to other institutes," said OBSSR Director Norman Anderson, Ph.D. "Although the specific topic areas haven't been identified as yet, the goal is to develop RFAs where we can get cross-institute collaborations."
Overall Increase
Much of the office's short-term activity will involve this kind of brokering, Anderson said. In the long run, he hopes the office will be able to increase funding for behavioral and social science research at all the institutes.
In September, the American Cancer Society established a Behavioral Research Unit at its headquarters in Atlanta. "Many of the issues that have to do with preventing cancer are really a matter of changing human behavior," said Frank Baker, Ph.D., director of the unit. "The various divisions around the country felt that we needed to have a stronger presence of behavioral science at the national home office... It was a feeling that we needed to do more in that area."
The unit will conduct some of its own studies, including policy research that would be politically off limits for NCI, Baker said. One study being considered is a massive, long-term investigation into the needs of the estimated 8 million cancer survivors and factors that relate to quality of life, including such issues as sexual dysfunction, cognitive dysfunction, and job discrimination.
"Research shows that there are lasting effects of treatment," Baker said. "I'm hoping that we can help to define those more specifically, have some hard data to describe them, and begin to address the policy issues."
In addition, the unit will be involved with translating into practice what has Dr. Frank Baker been learned about behavioral interventions. Baker said. It will also be available to other ACS entities to consult about behavioral and psychosocial aspects of cancer.
The National Cancer Institute of Canada, the research arm of the Canadian Cancer Society, has already established a network of centers for multisite studies in behavioral aspects of cancer and has started half a dozen pilot projects, ranging from quality of life to complementary therapies to physician/oncologist communications with patients. The hub of the network at NCIC is the Centre for Behavioural Research and Programme Evaluation, which now has nine satellite centers across Canada.
Canadian Priorities
"The Canadian Cancer Society's priorities are things like tobacco use reduction and quality of life for cancer patients," said Lori Lockyer, manager of the center. "What led to the behavioral initiative at NCIC was CCS's feeling that more research was needed in the behavioral area."
Later in 1996, the center will apply for funding of full-scale studies, and in 3 years' time it will conduct a site review, Lockyer said. "After that, depending on indicators of how we're doing, we'll probably expand the network."
-Hugh Mclntosh
Task Force Issues New Screening Guidelines
New cancer screening guidelines from the U.S. Preventive Health Services Task Force -an independent panel convened by the U.S. Public Health Service -have drawn criticism from the American Cancer Society and the American College of Radiology. The task force's 1989 guide to disease prevention is widely used; the 1995 guidelines update those published in 1989 and are likely to be relied on for insurance reimbursement.
Good News
The good news, said ACS, is that the task force has affirmed the value of annual screening for colorectal cancer with a fecal occult blood test for adults over age 50 (with sigmoidoscopy at unspecified intervals). In 1989, the task force said there was not enough evidence to recommend for or against colorectal cancer screening.
But the bad news, said ACS and ACR, is that the new screening guidelines recommend against routine screening for prostate cancer with a digital rectal examination or a prostate-specific antigen test, and do not advocate yearly mammograms for women ages 50 to 74 or for women over age 70 at any interval. In 1989, the task force recommended annual screening mammograms for women ages 50 to 74; the new guidelines recommend mammography screening every 1 to 2 years for women ages 50 to 69. U.S. Assistant Secretary for Health Philip R. Lee, M.D., hailed the 1995
